ArticleOncotarget2014

Discovery of novel non-ATP competitive FGFR1 inhibitors and evaluation of their anti-tumor activity in non-small cell lung cancer in vitro and in vivo.

Jianzhang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.